Proteologics

The company IPOed in 2010

GizaVC invests in the vision of Israel's most innovative entrepreneurs.

About

Proteologics is a biopharmaceutical company exploiting the ubiquitin system for the discovery and development of novel therapeutics. Proteologics accomplishes this through identifying correlations between ubiquitin pathway components and pathological conditions.   

proteo c

 

Proteologics went public on the Tel Aviv Stock Exchange in 2010

Established

1999

Founders

Gleb Zilberstein, Dr. Uriel (Uri) Halavee

Management

CEO: Josh Levine      Director of R&D: Dr. Daniel Taglicht

CFO: Esti Hayun        Head of Chemistry: Dr. Philippe Nakache

 

 

Fields of invesment:icon life Healthcare

Contact info: icon internetWebsite